NO991384L - Substituerte heterocykler som anti-tumormidler - Google Patents

Substituerte heterocykler som anti-tumormidler

Info

Publication number
NO991384L
NO991384L NO991384A NO991384A NO991384L NO 991384 L NO991384 L NO 991384L NO 991384 A NO991384 A NO 991384A NO 991384 A NO991384 A NO 991384A NO 991384 L NO991384 L NO 991384L
Authority
NO
Norway
Prior art keywords
compounds
formula
tumor agents
substituted heterocycles
useful
Prior art date
Application number
NO991384A
Other languages
English (en)
Other versions
NO991384D0 (no
Inventor
Edmond J Lavoie
Leroy Fong Liu
Darshan B Makhey
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Publication of NO991384D0 publication Critical patent/NO991384D0/no
Publication of NO991384L publication Critical patent/NO991384L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Den foreliggende oppfinnelse tilveiebringer forbindelsene fra formel (I) hvori Ri-R?, W, X, Y og Z har enhver av verdiene definert i beskrivelsen, og farmasøytisk akseptable salt derav, som er nyttige som anti-cancermidler. Også beskrevet er farmasøytiske sammensetninger som omfatter en eller flere forbindelser fra formel (I), metoder for fremstilling av forbindelsene fra formel (I) og intermediater nyttige for fremstilling av forbindelser fra formel (I).
NO991384A 1996-09-23 1999-03-22 Substituerte heterocykler som anti-tumormidler NO991384L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2651196P 1996-09-23 1996-09-23
PCT/US1997/017012 WO1998012181A1 (en) 1996-09-23 1997-09-23 Substituted heterocycles as anti-tumor agents

Publications (2)

Publication Number Publication Date
NO991384D0 NO991384D0 (no) 1999-03-22
NO991384L true NO991384L (no) 1999-05-20

Family

ID=21832257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991384A NO991384L (no) 1996-09-23 1999-03-22 Substituerte heterocykler som anti-tumormidler

Country Status (14)

Country Link
US (1) US5981541A (no)
EP (1) EP0950054A1 (no)
JP (1) JP2001501197A (no)
KR (1) KR20000048537A (no)
AU (1) AU725938B2 (no)
BR (1) BR9711296A (no)
CA (1) CA2266321A1 (no)
CZ (1) CZ102499A3 (no)
IL (1) IL129096A0 (no)
NO (1) NO991384L (no)
NZ (1) NZ334954A (no)
PL (1) PL332416A1 (no)
TR (1) TR199900636T2 (no)
WO (1) WO1998012181A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137351A0 (en) 1998-02-12 2001-07-24 Univ Rutgers Heterocyclic topoisomerase poisons
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US20070233272A1 (en) * 1999-02-23 2007-10-04 Boyce Todd M Shaped load-bearing osteoimplant and methods of making same
US8133421B2 (en) * 1999-02-23 2012-03-13 Warsaw Orthopedic, Inc. Methods of making shaped load-bearing osteoimplant
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
US20030139409A1 (en) 1999-12-02 2003-07-24 John Milton Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
GB9928542D0 (en) * 1999-12-02 2000-02-02 Xenova Ltd Pharmaceutical compounds
ES2293986T3 (es) * 2000-03-27 2008-04-01 N.V. Organon Compuestos no esteroides tetraciclicos para tratamientos relacionados con el estrogeno.
KR100381716B1 (ko) * 2000-10-09 2003-04-26 한국화학연구원 항암활성을 가지는 아크리딘 유도체
ATE405568T1 (de) 2001-11-14 2008-09-15 Univ Rutgers Cytotoxische mittel
CA2467279A1 (en) 2001-11-14 2003-06-26 Edmond J. Lavoie Solubilized topoisomerase poison agents
AU2002363658B2 (en) 2001-11-14 2008-09-11 Rutgers, The State University Solubilized topoisomerase poisons
DE60225943T2 (de) * 2001-11-14 2009-01-29 Rutgers, The State University Topoisomerase-giftmittel
US6992088B2 (en) * 2002-08-09 2006-01-31 Rutgers, The State University Of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
AU2003268075A1 (en) * 2002-08-09 2004-02-25 Edmond J. Lavoie Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
US6989387B2 (en) 2002-08-09 2006-01-24 Rutgers, The State University Of New Jersey Nitro and amino substituted topoisomerase agents
AU2003290818A1 (en) * 2002-11-12 2004-06-03 Edmond J. Lavoie Topoisomerase-targeting agents
JP5773888B2 (ja) 2009-03-06 2015-09-02 ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー 癌治療に用いられるメチレンジオキシベンゾ［ｉ］フェナントリジン誘導体
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
EP2592083A4 (en) * 2010-05-21 2014-01-22 Shenzhen Salubris Pharm Co Ltd CONDENSED CHINAZOLINE DERIVATIVES AND THEIR USES
CN102351870B (zh) * 2011-08-25 2014-03-12 中山大学 一种苯并吖啶衍生物的制备方法及其作为抗癌药物的用途
CN105669551B (zh) * 2015-12-02 2018-04-17 广西中医药大学 7‑苯并(c)吖啶对氟苯甲酰胺基硫脲及其制备方法和用途
EP3442979A4 (en) 2016-04-04 2019-12-18 Rutgers, the State University of New Jersey topoisomerase poisons

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US26065A (en) * 1859-11-08 Improvement in cotton-gins
US2981731A (en) * 1961-04-25 Acridine derivatives
USRE26065E (en) 1966-07-19 Folybenzimidazoles and their preparation
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
US2915523A (en) * 1956-12-03 1959-12-01 Parke Davis & Co Benzacridine compounds
US3272707A (en) * 1964-07-17 1966-09-13 Smith Kline French Lab Pharmaceutical compositions and methods for their use
CH420045A (de) * 1964-09-01 1967-03-15 Ciba Geigy Verwendung von neuen Poly-azolen als optische Aufhellmittel für textile organische Materialien
US3267107A (en) * 1964-09-17 1966-08-16 American Home Prod 3-(4'-5'-methylenedioxy-phenyl)-7, 8-dimethoxy-1, 2, 3, 4,-tetrahydroisoquinolines
US3849561A (en) * 1964-10-20 1974-11-19 S Naruto Anti-peptic ulcer substance from corydalis tubers
DE1670684A1 (de) * 1966-04-01 1970-12-03 Hoechst Ag Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
JPS4942700A (no) * 1972-08-25 1974-04-22
US4980344A (en) * 1982-05-14 1990-12-25 Maroko Peter R Compositions for improving circulatory performance
JPS61130289A (ja) * 1984-11-29 1986-06-18 Ss Pharmaceut Co Ltd １３−プロピルベルベリンの塩
US5244903A (en) * 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
JP2700475B2 (ja) * 1988-07-30 1998-01-21 コニカ株式会社 非線形光学材料および非線形光学素子
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5106863A (en) * 1990-03-26 1992-04-21 Ortho Pharmaceutical Corporation Substituted imidazole and pyridine derivatives
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US5126351A (en) * 1991-01-24 1992-06-30 Glaxo Inc. Antitumor compounds
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
DE69430752T2 (de) * 1993-09-28 2002-10-17 Kyowa Hakko Kogyo Co., Ltd. Tetracyclische verbindungen

Also Published As

Publication number Publication date
AU4589797A (en) 1998-04-14
TR199900636T2 (xx) 1999-10-21
BR9711296A (pt) 1999-08-17
PL332416A1 (en) 1999-09-13
NO991384D0 (no) 1999-03-22
IL129096A0 (en) 2000-02-17
US5981541A (en) 1999-11-09
NZ334954A (en) 2000-08-25
CZ102499A3 (cs) 1999-09-15
KR20000048537A (ko) 2000-07-25
EP0950054A1 (en) 1999-10-20
AU725938B2 (en) 2000-10-26
CA2266321A1 (en) 1998-03-26
WO1998012181A1 (en) 1998-03-26
JP2001501197A (ja) 2001-01-30

Similar Documents

Publication Publication Date Title
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
NO20085078L (no) Nye forbindelser
DE69725608D1 (de) Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel
NO20055714L (no) Inhibitorer av fosfatidylinositol 3-kinase
ATE316083T1 (de) Adamantanderivate
NO20040881L (no) Orale antidiabetes midler.
MX9803954A (es) Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos.
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
ATE300541T1 (de) Pyrazolopyridinderivate
TR199900636T2 (xx) Anti-t�m�r ajanlar� olarak ikameli/katk�l� heterosayk�llar.
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.
TR199900732T2 (xx) PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri.
EP0992509A3 (en) Novel macrolide derivatives
NO973652D0 (no) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyre og derivater som tachykininreseptor-antagonist
IS5588A (is) Æxliseyðandi miðlar
TR200103789T2 (tr) Tirozin kinaz inhibitörleri olarak ikameli 1,4-dihidroindeno[1,2-C]pirazoller.
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
DE69330601D1 (de) Serotoninergische ergolin derivate
YU31995A (sh) Benzotiofeni glikopiranozida, postupak za njihovo dobijanje i njihova farmaceutska formulacija
ES8604488A1 (es) Un procedimiento para la preparacion de un derivado de ace- tileno
EP1567508A4 (en) 1,2,4-TRIAZOLE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
SV2003001058A (es) Agentes antibacterianos pca494-01
EE03488B1 (et) Meetod anhüdroekgoniini estrite valmistamiseks

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application